The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 08, 2013

Filed:

Nov. 05, 2010
Applicants:

Donald R. Owen, New Orleans, LA (US);

David C. Kravitz, Chicago, IL (US);

John Brassil, Northbrook, IL (US);

Kelvin G. M. Brockbank, Charleston, SC (US);

Andrew Burroughs, Kenosha, WI (US);

Dickon Isaacs, Chicago, IL (US);

Dennis J. Steibel, Lake Zurich, IL (US);

Richard Fraser, Bartlett, IL (US);

Stanley Harris, Mt. Pleasant, SC (US);

Douglas Schein, Chicago, IL (US);

Inventors:

Donald R. Owen, New Orleans, LA (US);

David C. Kravitz, Chicago, IL (US);

John Brassil, Northbrook, IL (US);

Kelvin G. M. Brockbank, Charleston, SC (US);

Andrew Burroughs, Kenosha, WI (US);

Dickon Isaacs, Chicago, IL (US);

Dennis J. Steibel, Lake Zurich, IL (US);

Richard Fraser, Bartlett, IL (US);

Stanley Harris, Mt. Pleasant, SC (US);

Douglas Schein, Chicago, IL (US);

Assignee:

Lifeline Scientific, Inc., Itasca, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 1/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

An organ perfusion apparatus and method monitor, sustain and/or restore viability of organs and preserve organs for storage and/or transport. Other apparatus include an organ transporter, an organ cassette and an organ diagnostic device. Organ viability is restored by restoring high energy nucleotide (e.g., ATP) levels by perfusing the organ with a medical fluid, such as an oxygenated cross-linked hemoglobin-based bicarbonate medical fluid, at normothermic temperatures. In the hypothermic mode, the organ is perfused with a medical fluid, preferably a simple crystalloid solution containing antioxidants, intermittently or in slow continuous flow. Viability of the organ may be automatically monitored, preferably by monitoring characteristics of the medical fluid perfusate. The perfusion process can be automatically controlled using a control program.


Find Patent Forward Citations

Loading…